New NIAID Radiation and Nuclear Countermeasures Program’s DAIT Council-Approved Research Concepts (January 27, 2014)
BAA-13-100-SOL-00013: Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures for BARDA. Posted July 31, 2013
BAA-13-100-SOL-00014: Science and Technology Platforms Applied to Medical Countermeasure Development (Innovations) for BARDA. Posted July 31, 2013
RFA-DK-13-012: Intestinal Stem Cell Consortium Research Projects (U01) (co-funded by NIAID) – Receipt date Oct. 21, 2013.
PA-12-044: Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44])
PAR-09-027: Product development program to provide synthesis, scale- up production, analytical methods development, PK/ADME, formulation development, manufacture of Phase I supplies, GLP Tox, and product development planning. National Institutes of Health Rapid Access to Interventional Development (NIH-RAID Program) (X01).
HHS-NIH-NIAID(AI)-RFI-13-057: Request for Information – Radiation/Nuclear Countermeasure Product Development Support Services. Response Date Aug 19, 2013.
FY2014 NIH and CDC SBIR contract solicitation (PHS-2014-1) – Topic 332: Development of Radiation Modulators for Use during Radiotherapy. Deadline for Receipt: November 13, 2013.
RFP-BARDA-10-100-SOL-00025: BARDA Animal Model Development of Chemical, Biological, Radiological, and Nuclear; Influenza; and Emerging Infectious Disease Medical Countermeasures
Columbia CMCR Pilot Project Funds Now Available! Submission deadline: March 14, 2014. Download Submission Instructions (PDF)
Rochester CMCR Pilot Project Funds Now Available! Submission deadline: White Paper - February 3, 2014 Download Submission Instructions (PDF)
Last Updated October 31, 2013